In VivoUnder the leadership of industry veteran CEO Jeremy Levin and chief operating officer Meg Alexander, Ovid Therapeutics is making strategic moves to address unmet needs in neurology. In November 2024,
ScripScrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Bristol, VantAI Pair Technologies In Pr